The NSSP Support Team will present an overview on the plans for a future Master Facility Table user interface (UI) designed to replace the current excel-spreadsheet update process. The presentation will feature mock-ups of the UI screens, descriptions of the proposed functionality, and allow time for Q&A. The future UI is proposed to:
· Be supported through the AMC and allow sites to view, add, and edit facility information,
Definitions for BioSense 2.0 common syndromes.
The Department of Defense conducts syndromic surveillance of health encounter visits of Military Health System (MHS) beneficiaries. Providers within the MHS assign up to 10 diagnosis codes to each health encounter visit. The diagnosis codes are grouped into syndrome and sub-syndrome categories. On October 1, 2015, the Health and Human Services-mandated transition from ICD- 9-CM to ICD-10-CM required evaluation of the syndrome mappings to establish a baseline of syndrome rates within the DoD. The DoD data within the BioSense system currently utilizes DoD ESSENCE syndrome mappings. The Master Mapping Reference Table (MMRT) was developed by the CDC to translate diagnostic codes across the ICD-9-CM and ICD-10-CM encoding systems to prepare for the transition. The DoD ESSENCE and MMRT syndrome definitions are presented in this analysis for comparison.
Objective
The transition from ICD-9-CM to ICD-10-CM requires evaluation of syndrome mappings to obtain a baseline for syndromic surveillance purposes. Two syndrome mappings are evaluated in this report.
Abstract
OBJECTIVES:
Reliable methods are needed to monitor the public health impact of changing laws and perceptions about marijuana. Structured and free-text emergency department (ED) visit data offer an opportunity to monitor the impact of these changes in near-real time. Our objectives were to (1) generate and validate a syndromic case definition for ED visits potentially related to marijuana and (2) describe a method for doing so that was less resource intensive than traditional methods.
This is the technical weekly update report which the project director at the CDC (Mike Coletta) gets from the technical support company (ICF), summarizing the current status of work on the National Syndromic Surveillance (NSS) Platform.
From the BioSense 2.0 Onboarding Workgroup meeting, February 4, 2015
Presenter
Promise Nkwocha, MSc. RHCE, New York City Department of Health and Mental Hygiene
From the BioSense 2.0 Onboarding Workgroup Meeting, March 4, 2015
Presenter
Jill K Baber, MPH
Influenza and Syndromic Surveillance Coordinator
North Dakota Department of Health
Division of Disease Control
Join Michael Coletta, CDC Program Manager, for a presentation on the CDC National Syndromic Surveillance Program (NSSP - formerly known as BioSense). Following a thorough review of the BioSense Program in 2013, CDC initiated the BioSense Enhancement Initiative (BEI) which builds on the past successes, while addressing areas that need improvement, allowing for a national view of syndromic surveillance that will provide many additional public health benefits.
The HHS Region 10 workshop engaged nine participants from state and local public health departments in Idaho, Oregon, and Washington with experience in syndromic surveillance that ranged from less than 1 year to over 10 years. Representatives from Alaska, which is also in HHS Region 10, were unable to participate. Because the participants did not have access to actual emergency department (ED) syndromic surveillance data for sharing, the focus of the workshop was on building inter- jurisdictional understanding and sharing of practices.
Learning Objectives
The National Syndromic Surveillance Program (NSSP) conducted a three-part webinar series in 2016 to describe how data would flow to the BioSense Platform. This comprehensive series explored how data were to be ingested into the BioSense Platform and ESSENCE application and how BioSense 2.0 data were to be migrated.